| dc.date.accessioned | 1399-07-08T18:00:55Z | fa_IR |
| dc.date.accessioned | 2020-09-29T18:00:56Z | |
| dc.date.available | 1399-07-08T18:00:55Z | fa_IR |
| dc.date.available | 2020-09-29T18:00:56Z | |
| dc.date.issued | 2014-05-01 | en_US |
| dc.date.issued | 1393-02-11 | fa_IR |
| dc.identifier.citation | (2014). Diagnostic Significance of Combined Detection of Epstein-Barr Virus Antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for Nasopharyngeal Carcinoma. Asian Pacific Journal of Cancer Prevention, 15(5), 2001-2006. | en_US |
| dc.identifier.issn | 1513-7368 | |
| dc.identifier.issn | 2476-762X | |
| dc.identifier.uri | http://journal.waocp.org/article_28867.html | |
| dc.identifier.uri | https://iranjournals.nlai.ir/handle/123456789/34316 | |
| dc.description.abstract | The objective of this study was to investigate the diagnostic significance of EBV antibody combined detectionfor nasopharyngeal carcinoma (NPC) in a high incidence region of southern China. Two hundred and elevenuntreated NPC patients, 203 non-NPC ENT patients, and 210 healthy controls were recruited for the study. Thetiters of VCA/IgA and EA/IgA were assessed by immunoenzyme assay, and the levels of Rta/IgG and EBNA1/IgAwere determined by enzyme-linked immunosorbent assay. The levels of VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA demonstrated no association with gender or age (p>0.05). The receiver operating characteristic curve andthe area under the curve were used to evaluate the diagnostic value. The sensitivity of VCA/IgA (98.1%) andthe specificity of EA/IgA (98.5%) were the highest. When a logistic regression model was used to combine theresults from multiple antibodies to increase the accuracy, the combination of VCA/IgA+Rta/IgG, whose areaunder the curve was 0.99, had the highest diagnostic efficiency, and its sensitivity, specificity and Youden indexwere 94.8%, 98.0% and 0.93 respectively. The data suggest that the combination of VCA/IgA+Rta/IgG may bemost suitable for NPC serodiagnosis. | en_US |
| dc.format.extent | 539 | |
| dc.format.mimetype | application/pdf | |
| dc.language | English | |
| dc.language.iso | en_US | |
| dc.publisher | West Asia Organization for Cancer Prevention (WAOCP) | en_US |
| dc.relation.ispartof | Asian Pacific Journal of Cancer Prevention | en_US |
| dc.subject | Nasopharyngeal carcinoma | en_US |
| dc.subject | Epstein-Barr Virus | en_US |
| dc.subject | Antibody | en_US |
| dc.subject | Tumor marker | en_US |
| dc.subject | Serodiagnosis | en_US |
| dc.title | Diagnostic Significance of Combined Detection of Epstein-Barr Virus Antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for Nasopharyngeal Carcinoma | en_US |
| dc.type | Text | en_US |
| dc.citation.volume | 15 | |
| dc.citation.issue | 5 | |
| dc.citation.spage | 2001 | |
| dc.citation.epage | 2006 | |